生物防御市场：依产品、最终用户、地区

全球生物防御市场预计到2024年将达到165.1亿美元，预计2031年将达到271亿美元，2024年至2031年的复合年增长率为7.3%。

图 1. 生物防御市场占有率(%)，依地区划分，2024 年

生物防御涉及保护公民免受细菌、病毒、毒素和其他可用作反人类武器的生技药品等生物威胁。生物技术的进步增加了世界各地生物恐怖主义的威胁，增加了对强大生物防御系统的需求。生物恐怖主义是指故意使用病原微生物或毒素造成人类、动物或植物死亡或疾病。随着生物武器变得更加先进和易于获取，各国正在大力投资研究、检测、预防和应对措施，以保护公众健康。全球生物防御市场为威胁监测、医疗对策的储存和交付以及生物危害检测和回应培训提供创新的解决方案。

市场动态：

生物防御市场是由政府和非政府组织增加投资推动的，以促进对生物威胁的准备。世界各地生物恐怖主义案例数量不断增加，由于科学进步，生物武器的可用性不断增加，也迫使各国加强其生物防御基础设施和库存。然而，与生物防御系统的研究、开发和采购相关的高成本限制了更广泛的采用。此外，缺乏标准化的指导方针和法规也为市场相关人员带来了挑战。市场看到了加强新病原体检测技术和治疗方法研发力度的机会。经济实惠的便携式检测器的开发有可能在全部区域广泛使用。

本研究的主要特点

• 该研究报告对全球生物防御市场进行了深入分析，包括预测期内（2024-2031年，以2023年为基准年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球生物防御市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球生物防御市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球生物防御市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 全球生物防御市场，依产品，2019-2031

• 炭疽菌
• 天花
• 肉毒中毒
• 辐射
• 其他的

第六章 全球生物防御市场，依最终使用者划分，2019-2031 年

• 医院
• 门诊治疗中心
• 调查机构
• 军队
• 其他的

第七章 全球生物防御市场，按地区，2019-2031

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation.
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章 参考文献与调查方法

• 参考
• 调查方法

The global biodefense market is estimated to be valued at USD 16.51 Bn in 2024 and is expected to reach USD 27.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.

Figure 1. Biodefense Market Share (%), By Region, 2024

Biodefense involves protecting citizens from biological threats such as bacteria, viruses, toxins, and other biological agents that can be used as weapons against humanity. The rising threat of bioterrorism across the globe due to advancements in biotechnology has propelled the need for robust bio defense systems. Bioterrorism refers to the intentional use of pathogenic microorganisms or toxins to cause death or disease among humans, animals or plants. As bioweapons become more sophisticated and accessible, nations are investing heavily in research, detection, prevention and response measures to safeguard public health. The global bio defense market offers innovative solutions for threat surveillance, stockpiling and delivery of medical countermeasures, biohazard detection and response trainings.

Market Dynamics:

The bio defense market is driven by the increasing investments by government and non-government bodies to foster preparedness against biological threats. Escalating instances of bioterrorism globally and the growing accessibility of bioweapons through scientific advancement are also compelling nations to bolster their bio defense infrastructure and stockpiles. However, high costs associated with the research, development and procurement of bio defense systems limit wider adoption. Furthermore, lack of standardized guidelines and regulations pose challenges for market players. The market sees opportunities with growing R&D efforts for new pathogenic detection technologies and therapies. The development of affordable and portable bio detectors holds potential for broader usage across high-risk areas.

Key Features of the Study:

• This report provides an in-depth analysis of the global biodefense market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031, considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biodefense market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Emergent BioSolutions, SIGA Technologies Inc., Elusys Therapeutics, Inc., Altimmune, DynPort Vaccine Company LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biodefense market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodefense market.

Detailed Segmentation-

• By Product
  • Anthrax
  • Small Pox
  • Botulism
  • Radiation
  • Others
• By End User
  • Hospitals
  • Ambulatory Care Centers
  • Research Organizations
  • Military
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • XOMA corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation.
  • SIGA Technologies.
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems.
  • Dynport Vaccine Company.
  • Cleveland Biolabs.
  • Bavarian Nordic.
  • Ology Bioservices.
  • Alnylam Pharmaceuticals Inc
  • Takeda Pharmaceuticals
  • Chimerix, Inc.
  • Cleveland BioLabs, Inc.
  • Pluristem Therapeutics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Biodefense Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Biodefense Market, By Product, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Anthrax
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Small Pox
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Botulism
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Radiation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Biodefense Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ambulatory Care Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Military
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Biodefense Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • XOMA corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Altimmune Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emergent Biosolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynavax Technologies Corporation.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • SIGA Technologies.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Elusys Therapeutics Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ichor Medical Systems.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Dynport Vaccine Company.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland Biolabs.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bavarian Nordic.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ology Bioservices.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Alnylam Pharmaceuticals Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Chimerix, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cleveland BioLabs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pluristem Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact